Introduction
Ocular Hypertension - Overview
Ocular Hypertension - Therapeutics Development
Ocular Hypertension - Therapeutics Assessment
Ocular Hypertension - Companies Involved in Therapeutics Development
Ocular Hypertension - Drug Profiles
Ocular Hypertension - Dormant Projects
Ocular Hypertension - Discontinued Products
Ocular Hypertension - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Ocular Hypertension, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Ocular Hypertension - Pipeline by Aerie Pharmaceuticals Inc, H1 2020
Ocular Hypertension - Pipeline by Aerpio Pharmaceuticals Inc, H1 2020
Ocular Hypertension - Pipeline by Allergan Plc, H1 2020
Ocular Hypertension - Pipeline by Angelini Group, H1 2020
Ocular Hypertension - Pipeline by BioIVT, H1 2020
Ocular Hypertension - Dormant Projects, H1 2020
Ocular Hypertension - Dormant Projects, H1 2020 (Contd..1), H1 2020
Ocular Hypertension - Discontinued Products, H1 2020
Ocular Hypertension - Discontinued Products, H1 2020 (Contd..1), H1 2020

List of Figures
Number of Products under Development for Ocular Hypertension, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020

Companies Mentioned
• Aerie Pharmaceuticals Inc
• Aerpio Pharmaceuticals Inc
• Allergan Plc
• Angelini Group
• BioIVT
• Chong Kun Dang Pharmaceutical Corp
• D. Western Therapeutics Institute Inc
• Envisia Therapeutics Inc
• Kedalion Therapeutics Inc
• Kowa Company Ltd
• Laboratoires Thea SA
• Laboratorios Sophia SA de CV
• Lee’s Pharmaceutical Holdings Ltd
• Neurim Pharmaceuticals Ltd
• NicOx SA
• Novartis AG
• Noveome Biotherapeutics Inc
• Ocular Therapeutix Inc
• Ocuphire Pharma Inc
• Santen Pharmaceutical Co Ltd
• Senju Pharmaceutical Co Ltd
• Shenzhen Hornetcorn Bio-technology Company Ltd
• Sun Pharma Advanced Research Company Ltd
• Sustained Nano Systems LLC
• Sylentis SAU
• Taejoon Pharm Co Ltd
• Takeda Pharmaceutical Co Ltd
• ViSci Ltd
• Whitecap Biosciences LLC